A 26 Week Randomised, Multinational, Open Labelled, 2 Armed, Parallel Group, Treat-to-target Once Daily Treatment Trial With Insulin Detemir Versus Insulin Glargine, Both in Combination With Metformin in Subjects With Type 2 Diabetes
A 26 Week Randomised, Multinational, Open Labelled, 2 Armed, Parallel Group, Treat-to-target Once Daily Treatment Trial With Insulin Detemir Versus Insulin Glargine, Both in Combination With Metformin in Subjects With Type 2 Diabetes
This trial is conducted in Asia, South America and the United States of America (USA).
The aim of this clinical trial is to determine whether two insulin treatments given once daily are equally effective with respect to the blood glucose lowering effect in subjects with type 2 diabetes inadequately controlled on metformin treatment with or without an additional anti-diabetic drug (OAD).
Inclusion Criteria:
Exclusion Criteria:
Clilfton, New Jersey 07011, United States
Cayahoga Falls, Ohio 44223, United States
Capital Federal, 1405, Argentina
Capital Federal, 1429, Argentina
Thriruvananthapuram, 695 032, India